Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Oracle Surges 7% as AI Cloud Backlog Hits $664B, CoreWeave and Nebius Climb 4% (24/7 Wall St.) +++ ORACLE Aktie -4,63%

ELANCO Aktie

 >ELANCO Aktienkurs 
20.08 EUR    +1.9%    (TradegateBSX)
Ask: 19.88 EUR / 1010 Stück
Bid: 19.75 EUR / 1020 Stück
Tagesumsatz: 5 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ELANCO Aktie über LYNX handeln
>ELANCO Performance
1 Woche: -5,8%
1 Monat: +3,9%
3 Monate: +1,0%
6 Monate: -2,3%
1 Jahr: +24,1%
laufendes Jahr: +3,6%
>ELANCO Aktie
Name:  ELANCO ANIMAL HEALTH.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US28414H1032 / A2N6BH
Symbol/ Ticker:  5EA (Frankfurt) / ELAN (NYSE)
Kürzel:  FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN
Index:  -
Profil:  Elanco Animal Health Incorporated is an animal health company focused on developing, manufacturing, and marketing products for pets and farm animals. Its portfolio includes treatments and preventive solutions for parasitic control, dermatology, pain ..
>Volltext..
Marktkapitalisierung:  10541.23 Mio. EUR
Unternehmenswert:  13510.31 Mio. EUR
Umsatz:  4323.02 Mio. EUR
EBITDA:  883.55 Mio. EUR
Nettogewinn:  -171.37 Mio. EUR
Gewinn je Aktie:  -0.35 EUR
Schulden:  3374.02 Mio. EUR
Liquide Mittel:  456.41 Mio. EUR
Operativer Cashflow:  531.34 Mio. EUR
Bargeldquote:  0.29
Umsatzwachstum:  15.48%
Gewinnwachstum:  -147.3%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel 3 Insider kauften innerhalb der letzten 30 Tage Aktien im Wert von 981.553 Euro.
Suchwörter:  ELANCO
Letzte Datenerhebung:  11.09.26
>ELANCO Kennzahlen
Aktien/ Unternehmen:
Aktien: 499.62 Mio. St.
Frei handelbar: 98.98%
Rückkaufquote: -
Mitarbeiter: 9900
Umsatz/Mitarb.: 0.41 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 32.54%
Bewertung:
KGV: -
KGV lG: 20.94
KUV: 2.23
KBV: 1.77
PEG-Ratio: -
EV/EBITDA: 15.29
Rentabilität:
Bruttomarge: 44.28%
Gewinnmarge: -3.96%
Operative Marge: 6.63%
Managementeffizenz:
Gesamtkaprendite: -1.46%
Eigenkaprendite: -2.98%
>ELANCO Peer Group
Gesundheit, Tiermedizin/ Tierbehandlung
 
11.09.26 - 14:00
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement (PR Newswire)
 
INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail......
10.09.26 - 14:00
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference (PR Newswire)
 
INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Jeff Simmons, president and CEO, Bob VanHimbergen, executive vice president and CFO, and Bobby Modi,......
04.09.26 - 22:48
Elanco Director Purchases 40,000 Shares for $936,000 (Fool)
 
Purchasing 40,000 shares is a bullish signal for shareholders....
31.08.26 - 15:42
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility (Accesswire)
 
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline INDIANAPOLIS, IN / ACCESS Newswire / Aug......
26.08.26 - 14:33
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility (PR Newswire)
 
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline INDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the on-time completion of......
22.08.26 - 05:01
Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 935920 USD (Insiderkauf)
 
Kurzius, Lawrence Erik - Aufsichtsrat - Tag der Transaktion: 2026-08-20...
19.08.26 - 16:00
Director′s Confidence Visible as Elanco Leader Buys 10,000 Shares (Fool)
 
Insider buys into strength as the Elanco stock price has outperformed the S&P 500 over the last 12 months....
19.08.26 - 05:01
Insiderhandel: GC AND CORP SEC kauft Aktien von Elanco Animal Health im Wert von 94273 USD (Insiderkauf)
 
O'neill, Shiv - Vorstand - Tag der Transaktion: 2026-08-18...
14.08.26 - 01:01
Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 109100 USD (Insiderkauf)
 
Harrington, Michael J. - Aufsichtsrat - Tag der Transaktion: 2026-08-12...
13.08.26 - 20:36
Elanco: Fitch hebt Rating wegen erfolgreichen Schuldenabbaus an (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.08.26 - 13:48
Elanco (ELAN) Q2 2026 Earnings Call Transcript (Fool)
 
Zenrelia and Credelio Quattro drove blockbuster growth and margin expansion....
11.08.26 - 16:30
Elanco′s CLiK Extra Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species (Accesswire)
 
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical expertsEmergency Use Authorization for Elanco's CLiK Extra p......
11.08.26 - 00:01
Insiderhandel: EVP and CFO kauft Aktien von Elanco Animal Health im Wert von 96926 USD (Insiderkauf)
 
Vanhimbergen, Robert M. - Vorstand - Tag der Transaktion: 2026-08-07...
11.08.26 - 00:01
Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 236850 USD (Insiderkauf)
 
Herendeen, Paul - Aufsichtsrat - Tag der Transaktion: 2026-08-07...
07.08.26 - 20:24
Elanco′s CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Specie (PR Newswire)
 
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm......
07.08.26 - 15:54
Elanco granted FDA’s emergency nod for new world screwworm drug (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.26 - 00:36
Markets Slip as Rising Yields Pressure Tech | The Close 8/6/2026 (Bloomberg)
 
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Kestra Investment Management CIO Kara Murphy, e.l.f. Beauty CEO Tarang Amin, Klaviyo CEO & Co-Founder Andrew Bialecki, CAIS Founder, Chairman, & CEO Matt Brown, Manulife John Hancock Investments Co-Chief Investment Strategist Emily Roland, Placer.ai Analytical Research Head R.J. Hottovy, GoodRx CEO Wendy Barnes, Elanco Animal Health President & CEO Jeff Simmons, RXO CEO Drew Wilkerson, & The Conference Board CEO Steve Odland. (Source: Bloomberg)...
06.08.26 - 23:36
Elanco CEO on Boosted Forecast, Surge in Tick Bites (Bloomberg)
 
Elanco Animal Health President and CEO Jeff Simmons discusses what's behind the company's increased profit and revenue forecasts. Speaking on "Bloomberg The Close," Simmons also comments on the recent surge in tick bites and consumer spending on pet health products. (Source: Bloomberg)...
05.08.26 - 16:45
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
 
Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
05.08.26 - 15:27
Elanco posts Q2 beat as Zenrelia hits blockbuster status (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Werturteile sind nie Wahrheiten, sondern Wünsche, die meist erst wahr gemacht werden sollen. - Ludwig Marcuse
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!